CompletedNot Applicable

Nociception Level Monitor (NOL) During Guided Analgesic Delivery in Breast Surgeries

Denmark60 participantsStarted 2023-09-01

Plain-language summary

To assess if perioperative consumption of opioids can be optimized with the assistance of a Nociception Level (NOL) monitor in breast surgery patients receiving pectoral and parasternal nerve blocks as supplementation to general anaesthesia. Hypothesis: 1. NOL monitor guidance optimizes perioperative analgesic consumption and postoperative length of stay and offers a better quality of recovery in breast surgery. 2. Intraoperative NOL monitoring can detect the efficacy of pectoralis and parasternal nerve blocks. 3. Incidence of persistent neuropathic pain after breast cancer surgery is lower in patients receiving lower doses of perioperative opioids.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * American Society of Anaesthesiologists (ASA) class I-IV patients scheduled for an elective mastectomy with or without axillary resection Exclusion Criteria: * Inability to give consent, * atrial fibrillation, * local anesthetic allergy, * lumpectomy converted to Mastectomy.

What they're measuring

Peroperative Remifentanil consumption

Timeframe: during the surgery

Peroperative Morphine consumption

Timeframe: during the surgery

Trial details

NCT IDNCT05546021

SponsorUniversity of Southern Denmark

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-31

View on ClinicalTrials.gov More Anesthesia; Adverse Effect trials